Where AI Delivers Real Value in Pharma Today with Emily Lewis

About this episode

The episode discusses the current impact of AI in the pharmaceutical industry and the importance of immediate adoption.

Here’s what keeps pharma leaders awake at night: 70% to 80% of ChatGPT usage is healthcare-related; however, most pharmaceutical organizations still treat AI as a future consideration rather than an immediate competitive necessity. In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Emily Lewis, Artificial Intelligence and Innovation Lead for Digital Care Transformation at UCB, to explore why LLMs alone won’t move medicine forward, how to build cross-functional AI literacy ...

People in this episode

Host: Jonathan Kaskey

Guest: Emily Lewis

Topics covered

• AI in healthcare
• pharmaceutical industry
• cross-functional AI literacy
• regulatory workflows
• digital care transformation

Keywords

• AI
• pharma
• healthcare
• ChatGPT
• digital transformation
• regulatory impact
• cross-functional literacy

Mentioned in this episode

Organizations: UCB

Products: ChatGPT

More episodes of Pharma Sessions

• The Question Behind the Question - Field Training with Jennifer Muszik · June 8, 2026 · 29 min
• Why the Small Details Reveal Everything About Your CDMO Partner with Frank Sorce · May 28, 2026 · 30 min
• Why Medical Knowledge Isn’t Reaching Patients with Dr. Simon Chowdhury · May 21, 2026 · 37 min
• Timothy Smith on AI, Data, and Drug Discovery at Takeda · May 14, 2026 · 33 min
• Lessons on Leading Through Uncertainty in Pharma · May 7, 2026 · 36 min
• How Medical Affairs Becomes the Connector with Sonia Talwar · April 23, 2026 · 26 min